| Year |
Citation |
Score |
| 2020 |
Orgel E, Freyer DR, Ullrich NJ, Hardy KK, Thomas SM, Dvorak CC, Esbenshade AJ. Assessment of provider perspectives on otoprotection research for children and adolescents: A Children's Oncology Group Cancer Control and Supportive Care Committee survey. Pediatric Blood & Cancer. e28647. PMID 32886425 DOI: 10.1002/Pbc.28647 |
0.327 |
|
| 2020 |
Manoharan N, Choi J, Chordas C, Zimmerman MA, Scully J, Clymer J, Filbin M, Ullrich NJ, Bandopadhayay P, Chi SN, Yeo KK. Trametinib for the treatment of recurrent/progressive pediatric low-grade glioma. Journal of Neuro-Oncology. PMID 32780261 DOI: 10.1007/S11060-020-03592-8 |
0.393 |
|
| 2020 |
de Blank P, Li N, Fisher MJ, Ullrich NJ, Bhatia S, Yasui Y, Sklar CA, Leisenring W, Howell R, Oeffinger K, Hardy K, Okcu MF, Gibson TM, Robison LL, Armstrong GT, et al. Late morbidity and mortality in adult survivors of childhood glioma with neurofibromatosis type 1: report from the Childhood Cancer Survivor Study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32572180 DOI: 10.1038/S41436-020-0873-7 |
0.341 |
|
| 2020 |
Klesse LJ, Jordan JT, Radtke HB, Rosser T, Schorry E, Ullrich N, Viskochil D, Knight P, Plotkin SR, Yohay K. The Use of MEK Inhibitors in Neurofibromatosis Type 1-Associated Tumors and Management of Toxicities. The Oncologist. PMID 32272491 DOI: 10.1634/Theoncologist.2020-0069 |
0.366 |
|
| 2020 |
Miller DT, Cortés-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, ... Ullrich NJ, et al. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Genes. 11. PMID 32252413 DOI: 10.3390/Genes11040387 |
0.343 |
|
| 2020 |
Ullrich NJ, Prabhu SP, Reddy AT, Fisher MJ, Packer R, Goldman S, Robison NJ, Gutmann DH, Viskochil DH, Allen JC, Korf B, Cantor A, Cutter G, Thomas C, Perentesis JP, et al. A Phase II Study of Continuous Oral mTOR Inhibitor Everolimus for Recurrent, Radiographic-Progressive Neurofibromatosis Type 1-Associated Pediatric Low-Grade Glioma: A Neurofibromatosis Clinical Trials Consortium Study. Neuro-Oncology. PMID 32236425 DOI: 10.1093/Neuonc/Noaa071 |
0.301 |
|
| 2019 |
Plotkin SR, Duda DG, Muzikansky A, Allen J, Blakeley J, Rosser T, Campian JL, Clapp DW, Fisher MJ, Tonsgard J, Ullrich N, Thomas C, Cutter G, Korf B, Packer R, et al. Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901367. PMID 31626572 DOI: 10.1200/Jco.19.01367 |
0.302 |
|
| 2019 |
Partap S, Russo S, Esfahani B, Yeom K, Mazewski C, Embry L, Wheeler G, Ullrich NJ, Bowers DC. A Review of Chronic Leukoencephalopathy among Survivors of Childhood Cancer. Pediatric Neurology. PMID 31047756 DOI: 10.1016/J.Pediatrneurol.2019.03.006 |
0.322 |
|
| 2019 |
Miller DT, Freedenberg D, Schorry E, Ullrich NJ, Viskochil D, Korf BR. Health Supervision for Children With Neurofibromatosis Type 1. Pediatrics. PMID 31010905 DOI: 10.1542/Peds.2019-0660 |
0.341 |
|
| 2019 |
Zaazoue MA, Manley PE, Kapur K, Ullrich NJ, Silvera VM, Goumnerova LC. Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children. Neurosurgery. PMID 30989228 DOI: 10.1093/Neuros/Nyz078 |
0.31 |
|
| 2019 |
Ferner RE, Bakker A, Elgersma Y, Evans DGR, Giovannini M, Legius E, Lloyd A, Messiaen LM, Plotkin S, Reilly KM, Schindeler A, Smith MJ, Ullrich NJ, Widemann B, Sherman LS. From process to progress-2017 International Conference on Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis. American Journal of Medical Genetics. Part A. PMID 30908866 DOI: 10.1002/Ajmg.A.61112 |
0.365 |
|
| 2019 |
Zaazoue MA, Manley PE, Mehdar MA, Ullrich NJ, Dasenbrock HH, Chordas CA, Goumnerova LC. Optimizing Postoperative Surveillance of Pediatric Low-Grade Glioma Using Tumor Behavior Patterns. Neurosurgery. PMID 30892635 DOI: 10.1093/Neuros/Nyz072 |
0.335 |
|
| 2019 |
Silva KE, Rosner J, Ullrich NJ, Chordas C, Manley PE, Moulton EA. Pain affect disrupted in children with posterior cerebellar tumor resection. Annals of Clinical and Translational Neurology. 6: 344-354. PMID 30847366 DOI: 10.1002/Acn3.709 |
0.317 |
|
| 2019 |
Shih C, Blakeley J, Clapp DW, Armstrong AE, Wolters P, Dombi E, Cutter G, Ullrich NJ, Allen J, Packer R, Goldman S, Gutmann DH, Plotkin S, Rosser T, Robertson K, et al. Abstract CT233: Treatment of neurofibromatosis type 1 (NF1)-related plexiform neurofibromas (PN) with cabozantinib (XL184): A Neurofibromatosis Clinical Trials Consortium Phase II trial Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct233 |
0.353 |
|
| 2019 |
Manoharan N, Choi J, Chordas C, Zimmerman MA, Scully J, Clymer J, Ullrich NJ, Filbin M, Bandopadhayay P, Chi S, Yeo KK. LGG-12. TRAMETINIB FOR THE TREATMENT OF RECURRENT/PROGRESSIVE PEDIATRIC LOW GRADE GLIOMA: A SINGLE INSTITUTION EXPERIENCE Neuro-Oncology. 21: ii101-ii101. DOI: 10.1093/Neuonc/Noz036.155 |
0.307 |
|
| 2019 |
Whitecross S, Al Wattar B, Ullrich N, Heidary G. Test–retest reliability of goldmann perimetry in children with NF-1 associated optic pathway glioma Journal of American Association For Pediatric Ophthalmology and Strabismus. 23: e63. DOI: 10.1016/J.Jaapos.2019.08.230 |
0.31 |
|
| 2018 |
Seelisch J, Sung L, Kelly MJ, Raybin JL, Beauchemin M, Dvorak CC, Kelly KP, Nieder ML, Noll RB, Thackray J, Ullrich NJ, Cabral S, Dupuis LL, Robinson PD. Identifying clinical practice guidelines for the supportive care of children with cancer: A report from the Children's Oncology Group. Pediatric Blood & Cancer. e27471. PMID 30259647 DOI: 10.1002/Pbc.27471 |
0.324 |
|
| 2018 |
Bjornard KL, Gilchrist LS, Inaba H, Diouf B, Hockenberry MJ, Kadan-Lottick NS, Bowers DC, Dolan ME, Ullrich NJ, Evans WE, Ness KK. Peripheral neuropathy in children and adolescents treated for cancer. The Lancet. Child & Adolescent Health. 2: 744-754. PMID 30236383 DOI: 10.1016/S2352-4642(18)30236-0 |
0.339 |
|
| 2018 |
Robertson FC, Ullrich NJ, Manley PE, Al-Sayegh H, Ma C, Goumnerova LC. The Impact of Intraoperative Electrocorticography on Seizure Outcome After Resection of Pediatric Brain Tumors: A Cohort Study. Neurosurgery. PMID 30085120 DOI: 10.1093/Neuros/Nyy342 |
0.306 |
|
| 2018 |
Fisher MJ, Belzberg AJ, de Blank P, De Raedt T, Elefteriou F, Ferner RE, Giovannini M, Harris GJ, Kalamarides M, Karajannis MA, Kim A, Lázaro C, Le LQ, Li W, Listernick R, ... ... Ullrich NJ, et al. 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. 176: 1258-1269. PMID 29681099 DOI: 10.1002/Ajmg.A.38675 |
0.379 |
|
| 2018 |
Northman L, Morris M, Loucas C, Ross S, Muriel AC, Guo D, London WB, Manley P, Ullrich NJ. The Effectiveness of a Hospital-Based School Liaison Program: A Comparative Study of Parental Perception of School Supports for Children With Pediatric Cancer and Neurofibromatosis Type 1. Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses. 1043454218765140. PMID 29600747 DOI: 10.1177/1043454218765140 |
0.31 |
|
| 2018 |
Vuotto SC, Krull KR, Li C, Okcu MF, Bowers DC, Ullrich NJ, Srivastava D, Howell RM, Gibson TM, Leisenring WM, Oeffinger KC, Robison LL, Armstrong GT, Brinkman TM. Neurologic morbidities, psychological distress, and functional independence in adult survivors of childhood cancer treated with CNS-directed therapies: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 36: 10570-10570. DOI: 10.1200/Jco.2018.36.15_Suppl.10570 |
0.301 |
|
| 2018 |
de Blank P, Li N, Ullrich NJ, Fisher MJ, Bhatia S, Yasui Y, Sklar CA, Leisenring WM, Howell RM, Oeffinger KC, Hardy KK, Okcu MF, Gibson TM, Robison LL, Armstrong GT, et al. Neurofibromatosis type 1 and risk of late outcomes after a primary tumor: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 36: 10563-10563. DOI: 10.1200/Jco.2018.36.15_Suppl.10563 |
0.333 |
|
| 2018 |
Tonsgard J, Ullrich N, Blakeley J, Rosser T, Packer R, Korf B, Fisher M, Cutter G, Plotkin S, Karajannis M, Allen J, Wade Clapp D, Thomas C, Campian J. NFM-09. PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY Neuro-Oncology. 20: i144-i144. DOI: 10.1093/Neuonc/Noy059.517 |
0.326 |
|
| 2017 |
Dupuis LL, Kelly KM, Krischer JP, Langevin AM, Tamura RN, Xu P, Chen L, Kolb EA, Ullrich NJ, Sahler OJZ, Hendershot E, Stratton A, Sung L, McLean TW. Acupressure bands do not improve chemotherapy-induced nausea control in pediatric patients receiving highly emetogenic chemotherapy: A single-blinded, randomized controlled trial. Cancer. PMID 29266260 DOI: 10.1002/Cncr.31198 |
0.304 |
|
| 2017 |
Wells EM, Ullrich NJ, Seidel K, Leisenring W, Sklar CA, Armstrong GT, Diller L, King A, Krull KR, Neglia JP, Stovall M, Whelan K, Oeffinger KC, Robison LL, Packer RJ. Longitudinal Assessment of Late Onset Neurologic Conditions in Survivors of Childhood Central Nervous System Tumors: A Childhood Cancer Survivor Study Report. Neuro-Oncology. PMID 29016809 DOI: 10.1093/Neuonc/Nox148 |
0.363 |
|
| 2017 |
Peeler CE, Edmond JC, Hollander J, Alexander JK, Zurakowski D, Ullrich NJ, Manley PE, Heidary G. Visual and ocular motor outcomes in children with posterior fossa tumors. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus. PMID 28867398 DOI: 10.1016/J.Jaapos.2017.05.032 |
0.336 |
|
| 2017 |
Benitez V, Manley PE, Goumnerova LC, Harini C, Ullrich NJ. Brain tumors and epileptic spasms: Natural history and outcomes. Epilepsy & Behavior : E&B. 75: 25-28. PMID 28818811 DOI: 10.1016/J.Yebeh.2017.07.036 |
0.373 |
|
| 2017 |
Marinoff AE, Ma C, Guo D, Snuderl M, Wright KD, Manley PE, Al-Sayegh H, Sinai CE, Ullrich NJ, Marcus K, Haas-Kogan D, Goumnerova L, London WB, Kieran MW, Chi SN, et al. Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival. Journal of Neuro-Oncology. PMID 28733870 DOI: 10.1007/S11060-017-2568-8 |
0.378 |
|
| 2017 |
Blakeley JO, Bakker A, Barker A, Clapp W, Ferner R, Fisher MJ, Giovannini M, Gutmann DH, Karajannis MA, Kissil JL, Legius E, Lloyd AC, Packer RJ, Ramesh V, Riccardi VM, ... ... Ullrich NJ, et al. The path forward: 2015 International Children's Tumor Foundation conference on neurofibromatosis type 1, type 2, and schwannomatosis. American Journal of Medical Genetics. Part A. PMID 28436162 DOI: 10.1002/Ajmg.A.38239 |
0.384 |
|
| 2017 |
Plotkin S, Tonsgard J, Ullrich N, Allen J, Blakeley J, Rosser T, Campian J, Clapp W, Fisher M, Cutter G, Korf B, Packer R, Thomas C, Karjannis M. RARE-19. MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY Neuro-Oncology. 19: vi215-vi215. DOI: 10.1093/Neuonc/Nox168.868 |
0.328 |
|
| 2017 |
Robison N, Pauly J, Malvar J, Filbin M, de Mola RL, Dorris K, Bendel A, Bowers D, Bornhorst M, Gauvain K, Leary S, MacDonald T, Gardner S, Reddy A, Diaz P, ... ... Ullrich N, et al. PDCT-24. A PHASE I DOSE ESCALATION TRIAL OF THE MEK1/2 INHIBITOR MEK162 (BINIMETINIB) IN CHILDREN WITH LOW-GRADE GLIOMAS AND OTHER RAS-RAF PATHWAY-ACTIVATED TUMORS: INITIAL REPORT Neuro-Oncology. 19: vi189-vi189. DOI: 10.1093/Neuonc/Nox168.765 |
0.326 |
|
| 2016 |
King AA, Seidel K, Di C, Leisenring WM, Perkins SM, Krull KR, Sklar CA, Green DM, Armstrong GT, Zeltzer LK, Wells E, Stovall M, Ullrich NJ, Oeffinger KC, Robison LL, et al. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study. Neuro-Oncology. PMID 28039368 DOI: 10.1093/Neuonc/Now242 |
0.325 |
|
| 2016 |
Payne JM, Barton B, Ullrich NJ, Cantor A, Hearps SJ, Cutter G, Rosser T, Walsh KS, Gioia GA, Wolters PL, Tonsgard J, Schorry E, Viskochil D, Klesse L, Fisher M, et al. Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1. Neurology. 87: 2575-2584. PMID 27956565 DOI: 10.1212/Wnl.0000000000003435 |
0.309 |
|
| 2016 |
Wan MJ, Ullrich NJ, Manley PE, Kieran MW, Goumnerova LC, Heidary G. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. Journal of Neuro-Oncology. PMID 27311725 DOI: 10.1007/S11060-016-2163-4 |
0.351 |
|
| 2015 |
Ullrich NJ, Gordon LB. Hutchinson-Gilford progeria syndrome. Handbook of Clinical Neurology. 132: 249-64. PMID 26564085 DOI: 10.1016/B978-0-444-62702-5.00018-4 |
0.321 |
|
| 2015 |
Bandopadhayay P, Silvera VM, Ciarlini PD, Malkin H, Bi WL, Bergthold G, Faisal AM, Ullrich NJ, Marcus K, Scott RM, Beroukhim R, Manley PE, Chi SN, Ligon KL, Goumnerova LC, et al. Myxopapillary ependymomas in children: imaging, treatment and outcomes. Journal of Neuro-Oncology. PMID 26468139 DOI: 10.1007/S11060-015-1955-2 |
0.402 |
|
| 2015 |
Ullrich NJ. Neurocutaneous Syndromes and Brain Tumors. Journal of Child Neurology. PMID 26459515 DOI: 10.1177/0883073815604220 |
0.357 |
|
| 2015 |
Ullrich NJ, Pomeroy SL, Kapur K, Manley PE, Goumnerova LC, Loddenkemper T. Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors. Epilepsia. PMID 26332282 DOI: 10.1111/Epi.13112 |
0.558 |
|
| 2015 |
Weiss B, Widemann BC, Wolters P, Dombi E, Vinks A, Cantor A, Perentesis J, Schorry E, Ullrich N, Gutmann DH, Tonsgard J, Viskochil D, Korf B, Packer RJ, Fisher MJ. Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study. Neuro-Oncology. 17: 596-603. PMID 25314964 DOI: 10.1093/Neuonc/Nou235 |
0.344 |
|
| 2014 |
Plotkin SR, Albers AC, Babovic-Vuksanovic D, Blakeley JO, Breakefield XO, Dunn CM, Evans DG, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Kalamarides M, McClatchey AI, Messiaen L, Morrison H, ... ... Ullrich NJ, et al. Update from the 2013 International Neurofibromatosis Conference. American Journal of Medical Genetics. Part A. 164: 2969-78. PMID 25255738 DOI: 10.1002/Ajmg.A.36754 |
0.313 |
|
| 2014 |
Castellino SM, Ullrich NJ, Whelen MJ, Lange BJ. Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors Journal of the National Cancer Institute. 106. PMID 25080574 DOI: 10.1093/Jnci/Dju186 |
0.317 |
|
| 2014 |
Kim AH, Thompson EA, Governale LS, Santa C, Cahll K, Kieran MW, Chi SN, Ullrich NJ, Scott RM, Goumnerova LC. Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging. Journal of Neurosurgery. Pediatrics. 14: 356-64. PMID 25062303 DOI: 10.3171/2014.6.Peds1321 |
0.364 |
|
| 2014 |
Ross SG, Northman L, Morris M, Green AL, Ullrich NJ. Cerebellar mutism after posterior fossa tumor resection: case discussion and recommendations for psychoeducational intervention. Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses. 31: 78-83. PMID 24608700 DOI: 10.1177/1043454213518975 |
0.391 |
|
| 2014 |
Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN, Beroukhim R, Kieran MW, Manley PE. Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatric Blood & Cancer. 61: 1173-9. PMID 24482038 DOI: 10.1002/Pbc.24958 |
0.372 |
|
| 2014 |
Widemann BC, Acosta MT, Ammoun S, Belzberg AJ, Bernards A, Blakeley J, Bretscher A, Cichowski K, Clapp DW, Dombi E, Evans GD, Ferner R, Fernandez-Valle C, Fisher MJ, Giovannini M, ... ... Ullrich N, et al. CTF meeting 2012: Translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies. American Journal of Medical Genetics. Part A. 164: 563-78. PMID 24443315 DOI: 10.1002/Ajmg.A.36312 |
0.342 |
|
| 2014 |
King AA, Perkins SM, Seidel K, Di C, Leisenring WM, Krull KR, Sklar CA, Green DM, Armstrong GT, Zeltzer LK, Wells E, Stovall M, Ullrich N, Oeffinger KC, Robison LL, et al. Health and functional status of long-term adult medulloblastoma/PNet survivors: A report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology. 32: 9515-9515. DOI: 10.1200/Jco.2014.32.15_Suppl.9515 |
0.328 |
|
| 2013 |
Ullrich NJ, Kieran MW, Miller DT, Gordon LB, Cho YJ, Silvera VM, Giobbie-Hurder A, Neuberg D, Kleinman ME. Neurologic features of Hutchinson-Gilford progeria syndrome after lonafarnib treatment. Neurology. 81: 427-30. PMID 23897869 DOI: 10.1212/Wnl.0B013E31829D85C0 |
0.321 |
|
| 2013 |
Robison NJ, Prabhu SP, Sun P, Chi SN, Kieran MW, Manley PE, Cohen LE, Goumnerova L, Smith ER, Scott RM, London WB, Ullrich NJ. Predictors of neoplastic disease in children with isolated pituitary stalk thickening. Pediatric Blood & Cancer. 60: 1630-5. PMID 23670879 DOI: 10.1002/Pbc.24577 |
0.326 |
|
| 2013 |
Arrington DK, Danehy AR, Peleggi A, Proctor MR, Irons MB, Ullrich NJ. Calvarial defects and skeletal dysplasia in patients with neurofibromatosis Type 1. Journal of Neurosurgery. Pediatrics. 11: 410-6. PMID 23414129 DOI: 10.3171/2013.1.Peds12409 |
0.305 |
|
| 2013 |
Koss M, Scott RM, Irons MB, Smith ER, Ullrich NJ. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization. Journal of Neurosurgery. Pediatrics. 11: 417-25. PMID 23373626 DOI: 10.3171/2012.12.Peds12281 |
0.372 |
|
| 2013 |
Sung L, Zaoutis T, Ullrich NJ, Johnston D, Dupuis L, Ladas E. Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care. Pediatric Blood & Cancer. 60: 1027-30. PMID 23255159 DOI: 10.1002/Pbc.24426 |
0.358 |
|
| 2012 |
Ullrich NJ, Koss M, Scott RM, Smith ER. 168 Moyamoya Syndrome Associated with Neurofibromatosis Type 1 in Children. Neurosurgery. 71: E566. PMID 28175824 DOI: 10.1227/01.Neu.0000417757.72074.Ee |
0.34 |
|
| 2012 |
Gordon LB, Kleinman ME, Miller DT, Neuberg DS, Giobbie-Hurder A, Gerhard-Herman M, Smoot LB, Gordon CM, Cleveland R, Snyder BD, Fligor B, Bishop WR, Statkevich P, Regen A, Sonis A, ... ... Ullrich NJ, et al. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson-Gilford progeria syndrome. Proceedings of the National Academy of Sciences of the United States of America. 109: 16666-71. PMID 23012407 DOI: 10.1073/Pnas.1202529109 |
0.322 |
|
| 2012 |
Ullrich NJ, Embry L. Neurocognitive Dysfunction in Survivors of Childhood Brain Tumors Seminars in Pediatric Neurology. 19: 35-42. PMID 22641074 DOI: 10.1016/J.Spen.2012.02.014 |
0.356 |
|
| 2012 |
Ullrich NJ. Introduction. Neurologic sequelae of cancer in children Seminars in Pediatric Neurology. 19: 1-2. PMID 22641069 DOI: 10.1016/J.Spen.2012.02.009 |
0.319 |
|
| 2012 |
Manley PE, McKendrick K, McGillicudy M, Chi SN, Kieran MW, Cohen LE, Kothare S, Michael Scott R, Goumnerova LC, Sun P, London W, Marcus KJ, Pomeroy SL, Ullrich NJ. Sleep dysfunction in long term survivors of craniopharyngioma. Journal of Neuro-Oncology. 108: 543-9. PMID 22528788 DOI: 10.1007/S11060-012-0859-7 |
0.511 |
|
| 2012 |
Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, Packer RJ, Tabori U, Hoffman RO, Ardern-Holmes SL, Hummel TR, Hargrave DR, Bouffet E, Charrow J, Bilaniuk LT, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology. 14: 790-7. PMID 22474213 DOI: 10.1093/Neuonc/Nos076 |
0.345 |
|
| 2012 |
Rednam S, Scheurer M, Adesina A, Lau C, Okcu M, Deatrick J, Ogle S, Fisher M, Barakat L, Hardie T, Li Y, Ginsberg J, Ben-Arush M, Krivoy E, Rosenkranz R, ... ... Ullrich NJ, et al. QUALITY OF LIFE/AFTERCARE Neuro-Oncology. 14: i125-i139. DOI: 10.1093/Neuonc/Nos106 |
0.329 |
|
| 2011 |
Lin N, Baird L, Koss M, Kopecky KE, Gone E, Ullrich NJ, Scott RM, Smith ER. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression. Neurosurgical Focus. 31: E6. PMID 22133171 DOI: 10.3171/2011.10.Focus11228 |
0.34 |
|
| 2011 |
Ullrich NJ, Pomeroy SL. Neuro-oncology training for the child neurology resident. Seminars in Pediatric Neurology. 18: 120-2. PMID 22036496 DOI: 10.1016/J.Spen.2011.06.010 |
0.489 |
|
| 2011 |
Winkfield KM, Tsai HK, Yao X, Larson E, Neuberg D, Pomeroy SL, Ullrich NJ, Cohen LE, Kieran MW, Scott RM, Goumnerova LC, Marcus KJ. Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatric Blood & Cancer. 56: 1120-6. PMID 21488157 DOI: 10.1002/Pbc.22884 |
0.578 |
|
| 2011 |
Ullrich NJ, Zimmerman M, Smith E, Irons M, Marcus K, Kieran MW. Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1. Journal of Child Neurology. 26: 228-30. PMID 20823033 DOI: 10.1177/0883073810379639 |
0.331 |
|
| 2010 |
Wong JM, Chi SN, Marcus KJ, Levine BS, Ullrich NJ, MacDonald S, Lechpammer M, Goumnerova LC. Germinoma with malignant transformation to nongerminomatous germ cell tumor: Case report Journal of Neurosurgery: Pediatrics. 6: 295-298. PMID 20809716 DOI: 10.3171/2010.6.Peds09541 |
0.324 |
|
| 2010 |
Huttner AJ, Kieran MW, Yao X, Cruz L, Ladner J, Quayle K, Goumnerova LC, Irons MB, Ullrich NJ. Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1. Pediatric Blood & Cancer. 54: 890-6. PMID 20310005 DOI: 10.1002/Pbc.22462 |
0.406 |
|
| 2010 |
Ullrich NJ, Rey-Casserly C, Irons ML, Allison C, Irons MB. Children with segmental neurofibromatosis type 1 are at increased risk for academic and cognitive difficulties Journal of Pediatric Neurology. 8: 343-348. DOI: 10.3233/Jpn-2010-0411 |
0.323 |
|
| 2009 |
Ullrich NJ. Neurologic sequelae of brain tumors in children Journal of Child Neurology. 24: 1446-1454. PMID 19841432 DOI: 10.1177/0883073809342491 |
0.388 |
|
| 2009 |
Turner CD, Chordas CA, Liptak CC, Rey-Casserly C, Delaney BL, Ullrich NJ, Goumnerova LC, Scott RM, Begley HC, Fletcher WJ, Yao X, Chi S, Kieran MW. Medical, psychological, cognitive and educational late-effects in pediatric low-grade glioma survivors treated with surgery only. Pediatric Blood & Cancer. 53: 417-23. PMID 19479971 DOI: 10.1002/Pbc.22081 |
0.363 |
|
| 2009 |
Manley P, Li X, Turner C, Chi S, Zimmerman MA, Chordas C, Gordon A, Baker A, Ullrich NJ, Goumnerova L, Marcus K, Hoffman K, Kieran MW. A prospective, blinded analysis of A-PROTEIN (recoverin or CAR protein) levels in pediatric patients with central nervous system tumors. Pediatric Blood & Cancer. 53: 343-7. PMID 19422022 DOI: 10.1002/Pbc.22017 |
0.331 |
|
| 2009 |
Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA, Rorke-Adams LB, Fisher MJ, Janss A, Mazewski C, Goldman S, Manley PE, Bowers DC, Bendel A, Rubin J, ... ... Ullrich NJ, et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 385-9. PMID 19064966 DOI: 10.1200/Jco.2008.18.7724 |
0.381 |
|
| 2008 |
Gilheeney SW, Saad A, Chi S, Turner C, Ullrich NJ, Goumnerova L, Scott RM, Marcus K, Lehman L, De Girolami U, Kieran MW. Outcome of pediatric pineoblastoma after surgery, radiation and chemotherapy. Journal of Neuro-Oncology. 89: 89-95. PMID 18415046 DOI: 10.1007/S11060-008-9589-2 |
0.38 |
|
| 2008 |
Ullrich NJ, Pomeroy SL. Neurologic complications of pediatric systemic cancer Cancer Neurology in Clinical Practice: Neurologic Complications of Cancer and Its Treatment: Second Edition. 607-619. DOI: 10.1007/978-1-59745-412-4_32 |
0.459 |
|
| 2008 |
Ullrich NJ. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer Developmental Disabilities Research Reviews. 14: 229-237. DOI: 10.1002/Ddrr.30 |
0.389 |
|
| 2007 |
Ullrich NJ, Robertson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 68: 932-8. PMID 17372129 DOI: 10.1212/01.Wnl.0000257095.33125.48 |
0.598 |
|
| 2007 |
Saad AG, Sachs J, Turner CD, Proctor M, Marcus KJ, Wang L, Lidov H, Ullrich NJ. Extracranial metastases of glioblastoma in a child: Case report and review of the literature Journal of Pediatric Hematology/Oncology. 29: 190-194. PMID 17356401 DOI: 10.1097/Mph.0B013E31803350A7 |
0.369 |
|
| 2007 |
Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW. Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme. Journal of Neuro-Oncology. 82: 95-101. PMID 17031553 DOI: 10.1007/S11060-006-9251-9 |
0.345 |
|
| 2006 |
Ullrich NJ, Pomeroy SL. Molecular genetics of pediatric central nervous system tumors. Current Oncology Reports. 8: 423-9. PMID 17040620 DOI: 10.1007/S11912-006-0070-0 |
0.591 |
|
| 2006 |
Ullrich NJ, Marcus K, Pomeroy SL, Turner CD, Zimmerman M, Lehmann LE, Scott RM, Goumnerova L, Gillan E, Kieran MW, Chi SN. Transverse myelitis after therapy for primitive neuroectodermal tumors. Pediatric Neurology. 35: 122-5. PMID 16876009 DOI: 10.1016/J.Pediatrneurol.2006.01.013 |
0.565 |
|
| 2006 |
Ullrich NJ, Pomeroy SL. Microarray analysis and proteomic approaches to drug development Handbook of Brain Tumor Chemotherapy. 74-88. DOI: 10.1016/B978-012088410-0/50043-3 |
0.417 |
|
| 2005 |
Ullrich NJ, Scott RM, Pomeroy SL. Craniopharyngioma therapy: long-term effects on hypothalamic function. The Neurologist. 11: 55-60. PMID 15631644 DOI: 10.1097/01.Nrl.0000149971.27684.D4 |
0.565 |
|
| 2003 |
Ullrich NJ, Pomeroy SL. Pediatric brain tumors. Neurologic Clinics. 21: 897-913. PMID 14743655 DOI: 10.1016/S0733-8619(03)00014-8 |
0.595 |
|
| 2003 |
Pomeroy SL, Ullrich NJ. Development of the Nervous System Fetal and Neonatal Physiology: Third Edition. 2: 1675-1698. DOI: 10.1016/B978-0-7216-9654-6.50168-5 |
0.439 |
|
| Show low-probability matches. |